Japan has committed to annual drug price reviews whilst also expanding the scope by which the prices are deemed to …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

